Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NPDR - Non Proliferative Diabetic Retinopathy”

72 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 72 results

Testing effectiveness (Phase 2)Study completedNCT05383209
What this trial is testing

Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)

Who this might be right for
Nonproliferative Diabetic Retinopathy
EyePoint Pharmaceuticals, Inc. 77
Not applicableStudy completedNCT01145599
What this trial is testing

Identifying Progression of Retinal Disease in Eyes With NPDR in Diabetes Type 2 Using Non-invasive Procedures

Who this might be right for
Type 2 DiabetesNon Proliferative Diabetic Retinopathy
European Vision Institute Clinical Research Network 374
Testing effectiveness (Phase 2)Study completedNCT04692688
What this trial is testing

Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy

Who this might be right for
Diabetic RetinopathyDiabetic Macular EdemaNPDR - Non Proliferative Diabetic Retinopathy+1 more
Ocuphire Pharma, Inc. 103
Post-approval studies (Phase 4)Active Not RecruitingNCT06305143
What this trial is testing

Efficacy and Safety of Conbercept for Diabetic Macular Edema Combined With Severe Non-proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Macular Edema
Shanghai Eye Disease Prevention and Treatment Center 58
Testing effectiveness (Phase 2)Study completedNCT06599684
What this trial is testing

Study of INV-102 Ophthalmic Solution in Adults With Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy

Who this might be right for
Non-center Involved Diabetic Macular EdemaNon-center Involved Diabetic Macular Edema Associated With Non-proliferative Diabetic RetinopathyDiabetic Retinopathy+2 more
Invirsa, Inc. 19
Large-scale testing (Phase 3)Study completedNCT00131144
What this trial is testing

Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Novartis 583
Post-approval studies (Phase 4)UnknownNCT05386160
What this trial is testing

Phacoemulsification Combined With Intravitreal Injection of Ranibizumab Prevent Postoperative Capillary Non-perfusion Zone Progress in Non-proliferative Diabetic Retinopathy

Who this might be right for
Mild Non-proliferative Diabetic RetinopathyCataract DiabeticDiabetic Retinopathy
Ruijin Hospital 96
Not applicableUnknownNCT05222633
What this trial is testing

Anti-VEGF in Real-world

Who this might be right for
Neovascular Age-related Macular EdemaDiabetic Macular EdemaChoroidal Neovascular Membrane+3 more
Wenbin Wei 1,000
Testing effectiveness (Phase 2)UnknownNCT05007262
What this trial is testing

Tangningtongluo Tablet in the Treatment of Non-proliferative Diabetic Retinopathy

Who this might be right for
Type2 DiabetesDiabetic Retinopathy
Guizhou Bailing Group Pharmaceutical Co Ltd 240
Testing effectiveness (Phase 2)Looking for participantsNCT07259928
What this trial is testing

Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion

Who this might be right for
Non-Proliferative Diabetic RetinopathyRetinal Vein Occlusion
Annexin Pharmaceuticals AB 12
Testing effectiveness (Phase 2)Study completedNCT00198471
What this trial is testing

Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment

Who this might be right for
Vitreous DetachmentDiabetic Retinopathy
Bausch & Lomb Incorporated 10
Large-scale testing (Phase 3)Study completedNCT02718326
What this trial is testing

Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)

Who this might be right for
Nonproliferative Diabetic Retinopathy
Regeneron Pharmaceuticals 402
Post-approval studies (Phase 4)Ended earlyNCT00563043
What this trial is testing

Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment

Who this might be right for
Non Proliferative Diabetic RetinopathyProliferative Diabetic Retinopathy
Asociación para Evitar la Ceguera en México 8
Not applicableUnknownNCT01107132
What this trial is testing

Blood-retinal Barrier Imaging and Neuropsychiatric Sequela in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusNon-Proliferative Diabetic RetinopathyDiabetic Macular Edema
Soroka University Medical Center 100
Not applicableStudy completedNCT04636307
What this trial is testing

Characterization of Retinal Disease Progression in Eyes With Non Proliferative Diabetic Retinopathy in Diabetes Type 2 Using Non-invasive Procedures (CHART)

Who this might be right for
NPDR - Non Proliferative Diabetic RetinopathyDiabetes Mellitus, Type 2Retinal Disease
Association for Innovation and Biomedical Research on Light and Image 202
Testing effectiveness (Phase 2)Study completedNCT02435862
What this trial is testing

A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy

Who this might be right for
Non-Proliferative Diabetic Retinopathy
Allegro Ophthalmics, LLC 105
Large-scale testing (Phase 3)UnknownNCT04511715
What this trial is testing

Intravitreal Bevacizumab for Nonproliferative Diabetic Retinopathy

Who this might be right for
Non-proliferative Diabetic Retinopathy
Shahid Beheshti University of Medical Sciences 100
Testing effectiveness (Phase 2)Study completedNCT03197870
What this trial is testing

The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)

Who this might be right for
Nonproliferative Diabetic Retinopathy
EyePoint Pharmaceuticals, Inc. 167
Post-approval studies (Phase 4)UnknownNCT05358080
What this trial is testing

Study to Evaluate Efficacy and Safety of Entelon 50mg in Patients With Non-Proliferative Diabetic Retinopathy

Who this might be right for
Non Proliferative Diabetic Retinopathy
Hanlim Pharm. Co., Ltd. 396
Testing effectiveness (Phase 2)UnknownNCT05393284
What this trial is testing

Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy

Who this might be right for
Non-proliferative Diabetic RetinopathyProliferative Diabetic Retinopathy
Valo Health, Inc. 114
Next Page